Human Als3p Antibodies are Surrogate Markers of NDV-3A Vaccine Efficacy Against Recurrent Vulvovaginal Candidiasis
P. Uppuluri, S. Singh, A. Alqarihi, C. S. Schmidt, J. P. Hennessey, M. R. Yeaman, S. Filler, J. E. Edwards, A. S. Ibrahim
The paper evaluates anti-Als3p antibodies as surrogate markers for NDV-3A vaccine efficacy against recurrent vulvovaginal candidiasis by comparing vaccinated individuals with and without recurrence.
bioRxiv · May 17, 2018Immunology